Ankit Jain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ankit Jain has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Jeewan Ram Vishnoi
Department of Surgical Oncology All India Institute of Medical Sciences Jodhpur India
4 shared publications - Puneet Pareek
Department of Radiation Oncology All India Institute of Medical Sciences Jodhpur India
2 shared publications - Sanjeev Misra
All India Institute of Medical Sciences, Jodhpur, India
2 shared publications Ajai Sasidhar
Department of Surgical Oncology, All India Institute of Medical Sciences, Basni Industrial Area, Phase II, Jodhpur, India
1 shared publication- Ankita Chugh
Department of Dentistry, All India Institute of Medical Sciences, Jodhpur, India
1 shared publication Ankita Mody
AIIMS, Jodhpur
1 shared publication
Latest Publications
- 30 October 2025
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 17 (7) , 1-6
A New Classification System for Anatomic Variations in Axial Blood Supply of Pectoralis Major Muscle Flap: Do They Have an Impact on Flap Outcomes?
- 30 October 2025
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 17 (7) , 1-6
A New Classification System for Anatomic Variations in Axial Blood Supply of Pectoralis Major Muscle Flap: Do They Have an Impact on Flap Outcomes?
- 1 April 2025
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 11 (11) , e2400453
Snowflake Model: Redefining and Optimizing the Cancer Care Delivery System in Tier 2 and Tier 3 Cities in India
- 1 April 2025
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 11 (11) , e2400453
Snowflake Model: Redefining and Optimizing the Cancer Care Delivery System in Tier 2 and Tier 3 Cities in India
- Open Access
In-silico, interactomic and clinical validation based approach for screening and identification of miR biomarkers involved in Oral submucous fibrosis to Oral squamous cell carcinoma transition
Oral Squamous Cell Carcinoma (OSCC) is common preventable disease when diagnosed early, but mostly its progression follows transition from oral potentially malignant disorders (OPMDs) like Oral Submucous Fibrosis (OSF). However, it is difficult to predict possibilities of progression in these premalignant lesions hence, identification of molecular biomarkers would have major clinical impact in early diagnosis and better prognosis. In this context microRNA’s(miR’s) provide better opportunities in malignancy prediction and demarcation in OSF to OSCC transition as they perform key regulatory roles in many tumorigenic processes. Here, we computationally screened differentially expressed miR’s of OSCC and OSF from public databases followed by construction of protein interaction networks and enrichment analyses. The relevant miR’s were validated using qPCR of total 93 samplesincluding 34 OSCC, 30 OSF and 29 control blood and tissue samples. We identified significant down regulation of miR-133a-3p in OSCC compared to controls and interesting up-regulation compared to OSCC and control. miR-9-5p was up-regulated in OSF as well as OSCC and down-regulated in OSF compared to OSCC. Therefore, these two miR’s may serve as risk stratification biomarkers with validation in larger categorical datasets.
Open AccessIn-silico, interactomic and clinical validation based approach for screening and identification of miR biomarkers involved in Oral submucous fibrosis to Oral squamous cell carcinoma transition
Oral Squamous Cell Carcinoma (OSCC) is common preventable disease when diagnosed early, but mostly its progression follows transition from oral potentially malignant disorders (OPMDs) like Oral Submucous Fibrosis (OSF). However, it is difficult to predict possibilities of progression in these premalignant lesions hence, identification of molecular biomarkers would have major clinical impact in early diagnosis and better prognosis. In this context microRNA’s(miR’s) provide better opportunities in malignancy prediction and demarcation in OSF to OSCC transition as they perform key regulatory roles in many tumorigenic processes. Here, we computationally screened differentially expressed miR’s of OSCC and OSF from public databases followed by construction of protein interaction networks and enrichment analyses. The relevant miR’s were validated using qPCR of total 93 samplesincluding 34 OSCC, 30 OSF and 29 control blood and tissue samples. We identified significant down regulation of miR-133a-3p in OSCC compared to controls and interesting up-regulation compared to OSCC and control. miR-9-5p was up-regulated in OSF as well as OSCC and down-regulated in OSF compared to OSCC. Therefore, these two miR’s may serve as risk stratification biomarkers with validation in larger categorical datasets.
- Open Access
- 13 August 2019
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 10 (4) , 703-707
Paraneoplastic Syndrome Associated with the Retroperitoneal Dedifferentiated Liposarcoma: an Atypical Presentation and Review of the Literature
Retroperitoneal liposarcoma is usually asymptomatic until it is large enough to compress the surrounding organs. Here, we report a rare atypical case of primary retroperitoneal dedifferentiated liposarcoma who presented primarily with the misguiding and challenging paraneoplastic symptoms of high-grade fever and thrombocytosis instead of demonstrating the usual compressive symptoms. Such an extremely rare clinical presentation may mislead the diagnostic and treatment approach towards the search for medical causes, without a hint, that the tumor itself is causing these symptoms. Complete tumor excision usually leads to resolution of these paraneoplastic symptoms.
- 13 August 2019
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 10 (4) , 703-707
Open AccessParaneoplastic Syndrome Associated with the Retroperitoneal Dedifferentiated Liposarcoma: an Atypical Presentation and Review of the Literature
Retroperitoneal liposarcoma is usually asymptomatic until it is large enough to compress the surrounding organs. Here, we report a rare atypical case of primary retroperitoneal dedifferentiated liposarcoma who presented primarily with the misguiding and challenging paraneoplastic symptoms of high-grade fever and thrombocytosis instead of demonstrating the usual compressive symptoms. Such an extremely rare clinical presentation may mislead the diagnostic and treatment approach towards the search for medical causes, without a hint, that the tumor itself is causing these symptoms. Complete tumor excision usually leads to resolution of these paraneoplastic symptoms.
- 29 May 2019
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 51 (1) , 319-324
Hepatoblastoma in a Young Adult: a Rare Case Report and Review of the Literature
- 29 May 2019
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 51 (1) , 319-324
Hepatoblastoma in a Young Adult: a Rare Case Report and Review of the Literature